Second primary malignancy risk among patients with gastric cancer: a nationwide population-based study in Taiwan

[1]  F. Sung,et al.  Modest increase in risk of specific types of cancer types in type 2 diabetes mellitus patients , 2013, International journal of cancer.

[2]  H. Chung,et al.  Prediction of metachronous multiple primary cancers following the curative resection of gastric cancer , 2013, BMC Cancer.

[3]  P. Rajaraman,et al.  Risk factors associated with secondary sarcomas in childhood cancer survivors: a report from the childhood cancer survivor study. , 2012, International journal of radiation oncology, biology, physics.

[4]  H. Song,et al.  Metachronous Double Primary Cancer after Diagnosis of Gastric Cancer , 2012, Cancer research and treatment : official journal of Korean Cancer Association.

[5]  Henrik Toft Sørensen,et al.  Chronic obstructive pulmonary disease and cancer risk: a Danish nationwide cohort study. , 2012, Respiratory medicine.

[6]  S. Moss,et al.  Helicobacter pylori in the pathogenesis of gastric cancer and gastric lymphoma. , 2011, Cancer letters.

[7]  E. Björnsson,et al.  Increased risk for malignant neoplasms among patients with cirrhosis. , 2011, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[8]  A. Jemal,et al.  Global Cancer Statistics , 2011 .

[9]  A. Hasdemir,et al.  Second primary cancers in patients with gastric cancer , 2010, Radiology and oncology.

[10]  Jaw-Town Lin,et al.  Effective reduction of gastric cancer risk with regular use of nonsteroidal anti-inflammatory drugs in Helicobacter pylori-infected patients. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  B. Eom,et al.  Synchronous and metachronous cancers in patients with gastric cancer , 2008, Journal of surgical oncology.

[12]  T. Sohn,et al.  Surgical Outcome of Synchronous Second Primary Cancer in Patients with Gastric Cancer , 2007, Yonsei medical journal.

[13]  G. Morgan,et al.  Non-Hodgkin Lymphoma Secondary to Cancer Chemotherapy , 2007, Cancer Epidemiology Biomarkers & Prevention.

[14]  S. Lo,et al.  Multiple primary cancers in patients with gastric cancer. , 2006, Hepato-gastroenterology.

[15]  K. Yoo,et al.  Long term trends and the future gastric cancer mortality in Korea: 1983~2013. , 2006, Cancer research and treatment : official journal of Korean Cancer Association.

[16]  T. Hattori,et al.  A cohort study on second malignancies in gastrectomized patients with gastric cancer II. Second maliganacies in the gastric remnant , 1986, The Japanese journal of surgery.

[17]  R. Hoover,et al.  New malignancies among cancer survivors: SEER Cancer Registries, 1973-2000. , 2006 .

[18]  Y. Maehara,et al.  Effective follow‐up for recurrence or a second primary cancer in patients with early gastric cancer , 2005, The British journal of surgery.

[19]  Y. K. Park,et al.  Clinicopathological features of gastric carcinoma patients with other primary carcinomas , 2005, Langenbeck's Archives of Surgery.

[20]  M. Kubo,et al.  Secular trends in the incidence, mortality, and survival rate of gastric cancer in a general Japanese population: the Hisayama study , 2005, Cancer Causes & Control.

[21]  G. Vassal,et al.  Radiation dose, chemotherapy and risk of soft tissue sarcoma after solid tumours during childhood , 2004, International journal of cancer.

[22]  H. Kawanaka,et al.  Features of Second Primary Cancer in Patients with Gastric Cancer , 2003, Oncology.

[23]  Tsung-Mei Cheng.  Taiwan's new national health insurance program: genesis and experience so far. , 2003, Health affairs.

[24]  P. Maisonneuve,et al.  Associated primary tumors in patients with gastric cancer. , 2002, Journal of clinical gastroenterology.

[25]  Chien-Jen Chen,et al.  Cancer epidemiology and control in Taiwan: a brief review. , 2002, Japanese journal of clinical oncology.

[26]  A. Oshima,et al.  The risk for second primaries in gastric cancer patients: adjuvant therapy and habitual smoking and drinking. , 2000, Journal of Epidemiology.

[27]  H. Tsukuma,et al.  The risk of second malignancy after adjuvant chemotherapy for stomach cancer , 1999, Gastric Cancer.

[28]  Y. Nio,et al.  Second malignancies after a gastrectomy for gastric cancers: the effects of adjuvant therapies. , 1999, Anticancer research.

[29]  L. Mariani,et al.  Risk of second malignancies after surgical treatment for early gastric cancer , 1999, Gastric Cancer.

[30]  H. Taniguchi,et al.  Recent advances in surgical treatment have improved the survival of patients with gastric carcinoma , 1998, Cancer.

[31]  J. Fraumeni,et al.  Cancer incidence after retinoblastoma. Radiation dose and sarcoma risk. , 1997, JAMA.

[32]  Williams Cn.  Helicobacter pylori, gastric cancer and gastric MALT lymphoma. , 1996 .

[33]  L. Kalish,et al.  Second malignancies after treatment for laparotomy staged IA-IIIB Hodgkin's disease: long-term analysis of risk factors and outcome. , 1996, Blood.

[34]  T. Hiyama,et al.  Second Primary Cancer after Diagnosis of Stomach Cancer in Osaka, Japan , 1991, Japanese journal of cancer research : Gann.

[35]  H. Adami,et al.  The risk of gastrointestinal and other primary malignant diseases following gastric cancer. , 1991, Acta oncologica.

[36]  W. den Otter,et al.  Bone sarcomas linked to radiotherapy and chemotherapy in children. , 1988, The New England journal of medicine.

[37]  Y. Otani,et al.  Multiple primary cancers in the stomach and another organ: frequency and the effects on prognosis. , 1985, Japanese journal of clinical oncology.